Scrip’s Five Must-Know Things – 21 August 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: a look at global executive compensation; Pfizer’s new myeloma approval; Merck and Sichuan trump ADC breast cancer success; combo Alzheimer’s therapies in Eisai’s pipeline; and an overview of the state of gene therapy. https://scrip.pharmaintelligence.informa.com/SC148914/Quick-Listen-Scrips-Five-MustKnow-Things